Hope to resolve issues faced by Indians vaccinated with Covishield travelling to EU soon, says SII CEO Adar Poonawalla

By: |
June 28, 2021 2:14 PM

Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.

Adar PoonawallaSerum Institute of India chief executive officer Adar Poonawalla

Vaccine major Serum Institute of India chief executive officer Adar Poonawalla on Monday said he has taken up the issues faced by Indians who have taken the Covishield jab travelling to the European Union at highest levels and hoped to resolve them soon. Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.

“I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries,” Poonawalla said in a tweet.

As of now European Union (EU) recognises Vaxzevria (previously COVID-19 Vaccine AstraZeneca, Oxford). The other vaccines approved by the European Medicine Agency are Comirnaty by BioNTech-Pfizer, Moderna and Janssen (Johnson & Johnson).

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19: Himachal Pradesh revises travel guidelines for flyers
2Yamuna Riverfront Development project: Work on 3 stretches of 25-km project complete, says DDA
384 Kos Parikrama Marg in Ayodhya to be a national highway: Everything to know